Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma.
about
Advanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upCombination treatment including targeted therapy for advanced hepatocellular carcinomaSorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.Transarterial chemoembolization (TACE) plus sorafenib versus TACE for intermediate or advanced stage hepatocellular carcinoma: a meta-analysisIntermediate hepatocellular carcinoma: How to choose the best treatment modality?Sorafenib combined with transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis and systematic review.Sorafenib continuation or discontinuation in patients with unresectable hepatocellular carcinoma after a complete response.Role of transarterial chemoembolization in relation with sorafenib for patients with advanced hepatocellular carcinoma.Comparing the long-term efficacy of standard and combined minimally invasive procedures for unresectable HCC: a mixed treatment comparisonCombination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis.Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma.Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials.Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study.Health education helps to relieve postembolization pain during hepatic arterial chemoembolization therapyTransarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis
P2860
Q26851033-92351C57-50C6-44C5-997B-1FAC7380C395Q28077738-11FEC9A3-6831-4C8C-8728-71C1B2BCB45BQ33590407-AEE92B83-6F1A-4447-B92A-BF803B540DF9Q33778970-12C75D13-B875-41F0-98B8-923944259DAEQ35626764-8FE5C3DD-FBF7-40DE-89B2-C6225F8C1F58Q35917459-CC33726F-A412-43F9-AFAD-0DBDA80FB874Q36414519-46A79C9C-3F2B-4F32-B654-C72B403C662CQ37687559-B0E99168-6373-4BA4-B4CC-426C6AFCFC48Q37716505-00C7B883-CF60-4FFF-B806-2E19A3720149Q38197831-1B43992F-3C52-4EBE-8AE7-8622FF4A61B7Q38213650-986DF910-5E09-4C15-ADE0-24B071D8EDF8Q41172447-6B9E569C-EEBC-4BD4-A1CF-92336A553229Q41708999-F28077C4-0116-4649-940D-DB9586759AC9Q55259389-DA2DCE88-8AC9-4652-B881-98CB56A58A72Q57490366-A68CAB74-5723-4103-91E5-A7DD016958A8Q58765170-F98F9427-79C5-4F61-B100-9C5176991038
P2860
Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@en
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@nl
type
label
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@en
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@nl
prefLabel
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@en
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1476
Comparative effectiveness of t ...... for hepatocellular carcinoma.
@en
P2093
Adnan Muhammad
Ambuj Kumar
Branko Miladinovic
Donald Amodeo
Gitanjali Vidyarthi
Manish Dhamija
William Boyd
P2860
P304
P356
10.4254/WJH.V5.I7.364
P577
2013-07-01T00:00:00Z